|
KR20200115299A
|
|
Fibrosis-induced drug-eluting stent
|
|
KR102039634B1
|
|
A recombinant herpes simplex virus vector comprising the sequences of U38, U340 and U41
|
|
KR102052718B1
|
|
Method for preparing cnacer therapeutic HSV-1 vector using transformation step with herpes simplex virus including recombination of ICP6 region
|
|
KR20190116231A
|
|
Diagnosis for skin aging caused by increased formation of skin wrinkles
|
|
KR20190116232A
|
|
Diagnosis for skin aging caused by increased thickness of skin epithelial cells
|
|
KR20190116230A
|
|
Diagnosis for skin aging caused by skin photoaging
|
|
KR102039632B1
|
|
Method for preparing recombinant herpes simplex virus comprising ICP 6 deletion and GM-CSF gene
|
|
KR102039631B1
|
|
Method for preparing a recombinant herpes simplex virus vector comprising the sequences of U38, U340 and U41
|
|
KR102039633B1
|
|
A recombinant herpes simplex virus vector comprising GM-CSF gene
|
|
KR20190116229A
|
|
PCR primer set for detecting skin aging-specific Epigenetic gene markers
|
|
KR20210034280A
|
|
Nanoparticles including improved coatings and their uses
|
|
KR20210019306A
|
|
Method for producing spheroid using matrilin-3 primed stem cells, and an substance for treating cartilage disease obtained thereof
|
|
KR20210017823A
|
|
Pharmaceutical composition for preventing or treating myeloid leukemia
|
|
WO2021015342A1
|
|
Composition for preventing or treating spinal cord injury, comprising trpv4 antagonist
|
|
KR102198942B1
|
|
Genetically engineered mesenchymal stem cell for expressing pedf or overexpressing pedf compared to mother cell
|
|
KR20190082187A
|
|
Biomarkers for the diagnosis of ovarian cancer, indicating differences in expression levels
|
|
KR20190082186A
|
|
Biomarkers for the diagnosis of ovarian cancer associated with immune checkpoints
|
|
KR20190083321A
|
|
T cell-related biomarkers for diagnosis of ovarian cancer
|
|
KR20190082188A
|
|
Biomarkers for the treatment of ovarian cancer or prediction of recurrence after surgery
|
|
KR20200144397A
|
|
Biomarkers for predicting the response of patient with cancer to immune checkpoint inhibitor
|
